PHARMACEUTICAL FORMULATIONS, PROCESSES, SOLID FORMS AND METHODS OF USE RELATING TO 1-ETHYL-7-(2-METHYL-6-(1H-1,2,4-TRIAZOL-3-YL)PYRIDIN-3-YL)-3,4-DIHYDROPYRAZINO[2,3-B]PYRAZIN-2(1H)-ONE

Provided herein are solid forms of compound 1 having the structure of: methods for preparing solid forms of compound 1, phamiaceutical compositions comprising compound 1 and uses thereof in the treatment of cancer. La présente invention concerne des formulations, des procédés, des formes solides et...

Full description

Saved in:
Bibliographic Details
Main Authors XU, JEAN, BOERSEN, NATHAN, LI, YING, COHEN, BENJAMIN, PARIKH, DARSHAN K, LIANG, XIAOZHANG, LEE, THOMAS, KREILEIN, MATTHEW MICHAEL, MENON, ANIL, LEONG, WILLIAM WEI-HWA, VISKY, DORA
Format Patent
LanguageEnglish
French
Published 13.12.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Provided herein are solid forms of compound 1 having the structure of: methods for preparing solid forms of compound 1, phamiaceutical compositions comprising compound 1 and uses thereof in the treatment of cancer. La présente invention concerne des formulations, des procédés, des formes solides et des méthodes d'utilisation associés à la 1-éthyl-7-(2-méthyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one.
Bibliography:Application Number: CA20142909629